Harsam, Markjamo, in conversation with Alan Shortall a while ago he made the comment that US investors love medical device manufacturers. Given the current lack of enthuisiasm/understanding on the ASX for what Unilife is putting together, we may well see the move to NASDAQ become more of a priority than it has been. Would not be at all surprised either to see the idea of a dual listing canned and Unilife become a pure NASDAQ play. US investors are generally more willing to price in potential as is evidenced by the high PEs of many stocks on th NASDAQ still in the relatively early stages of their development. US investors/institutions also prefer ownership and control to reside in the US.
TDA, in answer to your earlier questions, the answer is yes, and M. Shortall had significant input re structuring of the Medpro deal.
A good weekend to all and hopefully a better week coming up.
Harsam, Markjamo, in conversation with Alan Shortall a while ago...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add UNI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$5.90 |
Change
0.020(0.34%) |
Mkt cap ! $451.8M | |||
| Open | High | Low | Value | Volume |
| $5.92 | $5.95 | $5.86 | $291.3K | 49.31K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 2228 | $5.89 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.90 | 70 | 2 |
View Market Depth
| Last trade - 15.13pm 24/07/2024 (20 minute delay) ? |
| UNI (ASX) Chart |